Provincial development of a patient-reported outcome initiative to guide patient care, quality improvement, and research-Reference-Cited by-同舟云学术

Provincial development of a patient-reported outcome initiative to guide patient care, quality improvement, and research

Published:2017-12-21 Issue:1 Volume:31 Page:13-17
ISSN:0840-4704
Container-title:Healthcare Management Forum
language:en
Short-container-title:Healthc Manage Forum

Author:

Olson Robert A.¹²³^ORCID,Howard Fuchsia²,Lapointe Vincent⁴,Schellenberg Devin⁴⁵,Nichol Alan⁴,Bowering Gale⁶,Curtis Susan⁵,Walter Allison⁴,Brown Steven¹,Thompson Corinne⁷,Bergin Jackie⁷,Lomas Sheri⁴,French John⁴,Halperin Ross⁷,Tyldesley Scott⁴,Beckham Wayne⁸

Affiliation:

1. BC Cancer Agency, Centre for the North, Prince George, British Columbia, Canada.

2. Department of Surgery, Division of Radiation Oncology, University of British Columbia, Vancouver, British Columbia, Canada.

3. Department of Interdisciplinary Studies, University of Northern British Columbia, Prince George, British Columbia, Canada.

4. BC Cancer Agency, Vancouver Centre, Vancouver, British Columbia, Canada.

5. BC Cancer Agency, Fraser Valley Centre, Surrey, British Columbia, Canada.

6. BC Cancer Agency, Abbotsford Centre, Abbotsford, British Columbia, Canada.

7. BC Cancer Agency, Centre for the Southern Interior, Kelowna, British Columbia, Canada.

8. BC Cancer Agency, Vancouver Island Centre, Victoria, British Columbia, Canada.

Abstract

The BC Cancer Agency Radiotherapy (RT) program started the Prospective Outcomes and Support Initiative (POSI) at all six centres to utilize patient-reported outcomes for immediate clinical care, quality improvement, and research. Patient-reported outcomes were collected at time of computed tomography simulation via tablet and 2 to 4 weeks post-RT via either tablet or over the phone by a registered nurse. From 2013 to 2016, patients were approached on 20,150 attempts by POSI for patients treated with RT for bone metastases (52%), brain metastases (11%), lung cancer (17%), gynecological cancer (16%), head and neck cancer (2%), and other pilots (2%). The accrual rate for all encounters was 85% (n = 17,101), with the accrual rate varying between the lowest and the highest accruing centre from 78% to 89% ( P < .001) and varying by tumour site ( P < .001). Using the POSI database, we have performed research and quality improvement initiatives that have changed practice.

Funder

Varian Medical Systems

Publisher

SAGE Publications

Subject

Health Policy

Link

http://journals.sagepub.com/doi/pdf/10.1177/0840470417715478

Reference21 articles.

1. What Is the Value of the Routine Use of Patient-Reported Outcome Measures Toward Improvement of Patient Outcomes, Processes of Care, and Health Service Outcomes in Cancer Care? A Systematic Review of Controlled Trials

2. Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial

3. Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)